News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mosbrooker Eric
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/15/2020 |
4
| Mosbrooker Eric (SVP, Chief Commercial Officer) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Unknown transaction of 26,919 shares
@ $60, valued at
$1.6M
Disposed/sold 87,750 options to buy
@ $22.01, valued at
$1.9M
|
|
| 12/16/2019 |
4
| Mosbrooker Eric (SVP, Chief Commercial Officer) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,881 shares
@ $59.37, valued at
$289.8k
|
|
| 01/04/2019 |
4
| Mosbrooker Eric (SVP, Chief Commercial Officer) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 31,500 shares
@ $0
Granted 87,750 options to buy
@ $22.01, valued at
$1.9M
|
|
| 01/04/2019 |
3
| Mosbrooker Eric (SVP, Chief Commercial Officer) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 11/02/2017 |
4
| Mosbrooker Eric (SVP, Orphan Business Unit) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 2,315 shares
@ $13.83, valued at
$32k
Exercised 4,435 restricted stock units
@ $0 |
|
| 08/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|